A study to evaluate the preoperative blood markers influencing the outcomes in patients of Pancreatic cancer
Not Applicable
- Conditions
- Health Condition 1: C25- Malignant neoplasm of pancreas
- Registration Number
- CTRI/2022/10/046383
- Lead Sponsor
- not applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients who underwent elective pancreatic cancer surgery (if curative) in TMH during the time period Jan 2017 to Dec 2019.
2.Patients who have received NACT and or RT prior to surgery.
Exclusion Criteria
1.All inoperable cases during the study period.
2.Patients who have preoperative clinical evidence of non hepato-biliary source of infection or other chronic inflammatory conditions like arthritis, SLE, etc. will be excluded from the study.
3.Patients on treatment with steroids.
4.Patients with psychiatric disorders on treatment with medications.
5.Patients on therapeutic heparin within 10 days before surgery.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method